TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 615-621

  Ni, Xiao Yan ^a   Sui, Hua Xiu ^a   Liu, Yao ^a   Ke, Shi Zhong ^a   Wang, Yi Nan ^a   Gao, Feng Guang ^a,b  

^a XIAMEN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

B7H1; Dendritic cells; GITRL; Regulatory T cells; Tumor microenvironment

Indexed keywords

4 CHLOROMETHYL 7 HYDROXYCOUMARIN; CARBOXYFLUORESCEIN SUCCINIMIDYL ESTER; COUMARIN DERIVATIVE; ESTER DERIVATIVE; PROGRAMMED DEATH 1 LIGAND 1; PROTEIN GITRL; TRANSFORMING GROWTH FACTOR BETA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; DENDRITIC CELL SARCOMA; DISEASE ASSOCIATION; FEMALE; FIBROBLAST CULTURE; FLOW CYTOMETRY; IN VITRO STUDY; INTRACELLULAR SIGNALING; LABELING INDEX; LEWIS CARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LYMPHOMA CELL LINE; MOLECULAR MODEL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TUMOR MICROENVIRONMENT; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD274; CARCINOMA, LEWIS LUNG; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT; TUMOR NECROSIS FACTORS; UP-REGULATION;

EID: 84863496897     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1822     Document Type: Article

References (34)

1. Witz IP: The tumor microenvironment: the making of a paradigm. Cancer Microenviron 2 (Suppl 1): 9-17, 2009.
2. Mueller MM and Fusenig NE: Friends or foes - bipolar effects of the tumor stroma in cancer. Nat Rev Cancer 4: 839-849, 2004. (Pubitemid 39472951)
3. Barsky SH, Green WR, Grotendorst GR and Liotta LA: Desmoplastic breast carcinoma as a source of human myofibroblasts. Am J Pathol 115: 329-333, 1984. (Pubitemid 14121182)
4. Kalluri R and Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 6: 392-401, 2006.
5. Zou WP: Immunosuppressive networks in the tumor environment and their therapeutic relevance. Nat Rev Cancer 5: 263-274, 2005.
6. Bergmann C, Strauss L, Zeidler R, Lang S and Whiteside TL: Expansion and characteristics of human T regulatory type 1 cells in co-cultures simulating tumor microenvironment. Cancer Immunol Immunother 56: 1429-1442, 2007. (Pubitemid 47024702)
7. Zou WP, Machelon V, Coulomb-L'Hermin A, et al: Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7: 1339-1346, 2001. (Pubitemid 34007939)
8. Iwamoto M, Shinohara H, Miyamoto A, et al: Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104: 92-97, 2003. (Pubitemid 36184151)
9. Gao F, Hui X, He X, Wan D and Gu J: Dysfunction of murine dendritic cells induced by incubation with tumor cells. Cell Mol Immunol 5: 133-140, 2008.
10. + regulatory T cells through the production of TGF-β1. World J Gastroenterol 17: 2019-2027, 2011.
11. Sempere LF, Gunn JR and Korc M: A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells. Cancer Biol Ther 12: 198-207, 2011.
12. Yi T, Li X, Yao S, et al: Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7.1 in allogeneic recipients. J Immunol 186: 2739-2749, 2011.
13. Zhou X, Zhou Y, Ding Q, et al: High level expression of B7H1 molecules by keratinocytes suppresses xeno- and allo-reactions by inducing type I regulatory T cells. Transpl Immunol 21: 192-197, 2009.
14. Hori J, Taniguchi H, Wang M, Oshima M and Azuma M: GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts. Invest Ophthalmol Vis Sci 51: 6556-6565, 2010.
15. Kim JI, Sonawane SB, Lee MK, et al: Blockade of GITR-GITRL interaction maintains Treg function to prolong allograft survival. Eur J Immunol 40: 1369-1374, 2010.
16. Häkkinen L, Koivisto L and Larjava H: An improved method for culture of epidermal keratinocytes from newborn mouse skin. Methods Cell Sci 23: 189-196, 2011.
17. Gao FG, Li HT, Li ZJ and Gu JR: Nicotine stimulated dendritic cells could achieve anti-tumor effects in mouse lung and liver cancer. J Clin Immunol 31: 80-88, 2011.
18. Zhang MH, Tang H, Guo ZH, et al: Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 5: 1124-1133, 2004. (Pubitemid 39549626)
19. Ruan Q, Kameswaran V, Tone Y, et al: Development of Foxp3(+) regulatory T cells is driven by the c-Rel enhanceosome. Immunity 31: 932-940, 2009.
20. Massague J: TGF-beta and cancer. Cell 134: 215-230, 2008.
21. Alshaker HA and Matalka KZ: IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: the significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int 11: 33, 2011.
22. Yang L, Pang Y and Moses HL: TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression. Trends Immunol 31: 220-227, 2010.
23. Siegel PM and Massague J: Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer. Nat Rev Cancer 3: 807-821, 2003.
24. Orsini E, Guarini A, Chiaretti S, Mauro FR and Foa R: The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. Cancer Res 63: 4497-4506, 2003. (Pubitemid 36951022)
25. Sharma S, Stolina M, Yang SC, et al: Tumor cyclooxygenase 2-dependent suppression of dendritic cell function. Clin Cancer Res 9: 961-968, 2003. (Pubitemid 36323698)
26. Yang AS and Lattime EC: Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cell to stimulate CD4 and CD8 T-cell responses. Cancer Res 63: 2150-2157, 2003. (Pubitemid 36538620)
27. Nam JS, Terabe M, Kang MJ, et al: Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 68: 3915-3923, 2008.
28. Gorska AE, Jensen RA, Shyr Y, Aakre ME, Bhowmick NA and Moses HL: Transgenic mice expressing a dominant-negative mutant type II transforming growth factor beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol 163: 1539-1549, 2003. (Pubitemid 37175100)
29. hi CD4 T cells is independent of direct TCR stimulation and requires IL-2, IL-10 and TGFβ. PLoS Pathog 5: e1000543, 2009.
30. Bettelli E, Carrier Y, Gao W, et al: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238, 2006.
31. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC and von Boehmer H: Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227, 2005. (Pubitemid 43045633)
32. + regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29: 114-126, 2008.
33. + regulatory T cells by antigen-processing dendritic cells. J Exp Med 198: 235-247, 2003.
34. Benson MJ, Pino-Lagos K, Rosemblatt M and Noelle RJ: All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J Exp Med 204: 1765-1774, 2007. (Pubitemid 47236315)